Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To evaluate the similarity of the efficacy and safety of semaglutide injection (QLG2065) vs. Ozempic® in patients with type 2 diabetes mellitus (T2DM) with poor blood glucose control after metformin treatment.
Epistemonikos ID: e07175d443c3dee4e9e17f89682405bb971b07cb
First added on: May 15, 2024